Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOSAVANCE for Bone Loss in Gynecologic Malignancies
NCT00593580Phase 2Completed
- Sponsor
- BC Cancer
- Start
- Feb 2008
- Primary completion
- Jun 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of alendronate + cholecalciferol in osteoporosis, sponsored by BC Cancer. Started Feb 2008; status: completed.
02
Drugs
alendronate + cholecalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00593580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00593580.